{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:13:23Z","timestamp":1793384003080,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T00:00:00Z","timestamp":1665964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T00:00:00Z","timestamp":1665964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To ascertain whether intravenous infusion of calcitonin gene-related peptide (CGRP) can induce migraine-like headache in people with persistent post-traumatic headache attributed to mild traumatic brain injury (TBI) and no pre-existing migraine.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A non-randomized, single-arm, open-label study at a single site in Denmark. Eligible participants were aged 18 to 65 years and had a known history of persistent post-traumatic headache attributed to mild TBI for \u2265\u200912 months. All participants received continuous intravenous infusion of CGRP (1.5\u00a0\u00b5g\/min) over 20\u00a0min. A headache diary was used to collect outcome data until 12\u00a0h after the start of CGRP infusion. The primary end point was the incidence of migraine-like headache during 12-hour observational period.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 60 participants completed the study protocol and provided data for the analysis of the primary end point. The median age was 32.5 (IQR, 25.5\u201343.0) years; 43 participants (72%) were female. Following CGRP infusion, 43 (72%) of 60 participants developed migraine-like headache during the 12-hour observational period. The median time to peak headache intensity was 40\u00a0min (IQR, 20\u201360), and the median peak headache intensity was 6 (IQR, 5\u20138) on the 11-point numeric rating scale.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Intravenous infusion of CGRP is a potent inducer of migraine-like headache in people with persistent post-traumatic headache attributed to mild TBI. This observation underscores the importance of CGRP in the genesis of migraine-like headache that is often experienced by individuals who are afflicted by persistent post-traumatic headache. Further research is warranted to ascertain whether other signaling molecules also contribute to the disease mechanisms underlying post-traumatic headache.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s10194-022-01499-5","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T12:08:16Z","timestamp":1666008496000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["CGRP-induced migraine-like headache in persistent post-traumatic headache attributed to mild traumatic brain injury"],"prefix":"10.1186","volume":"23","author":[{"given":"H\u00e5kan","family":"Ashina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afrim","family":"Iljazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidar M.","family":"Al-Khazali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thien Phu","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna K.","family":"Eigenbrodt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eigil L.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalie M.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karoline B.","family":"Br\u00e4uner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basit Ali","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casper E.","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal Mohammad","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik W.","family":"Schytz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,17]]},"reference":[{"issue":"6","key":"1499_CR1","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/S1474-4422(21)00094-6","volume":"20","author":"H Ashina","year":"2021","unstructured":"Ashina H, Eigenbrodt AK, Seifert T, Sinclair AJ, Scher AI, Schytz HW, Lee MJ, de Icco R, Finkel AG, Ashina M (2021) Post-traumatic headache attributed to traumatic brain injury: classification, clinical characteristics, and treatment. Lancet Neurol 20(6):460\u2013469. https:\/\/doi.org\/10.1016\/S1474-4422(21)00094-6","journal-title":"Lancet Neurol"},{"issue":"16","key":"1499_CR2","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1177\/0333102411428954","volume":"31","author":"D Lieba-Samal","year":"2011","unstructured":"Lieba-Samal D, Platzer P, Seidel S, Klaschterka P, Knopf A, Wober C (2011) Characteristics of acute posttraumatic headache following mild head injury. Cephalalgia 31(16):1618\u20131626. https:\/\/doi.org\/10.1177\/0333102411428954","journal-title":"Cephalalgia"},{"issue":"2","key":"1499_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1177\/0333102413499645","volume":"34","author":"S Lucas","year":"2014","unstructured":"Lucas S, Hoffman JM, Bell KR, Dikmen S (2014) A prospective study of prevalence and characterization of headache following mild traumatic brain injury. Cephalalgia 34(2):93\u2013102. https:\/\/doi.org\/10.1177\/0333102413499645","journal-title":"Cephalalgia"},{"issue":"7","key":"1499_CR4","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/S1474-4422(17)30117-5","volume":"16","author":"J van der Naalt","year":"2017","unstructured":"van der Naalt J, Timmerman ME, de Koning ME, van der Horn HJ, Scheenen ME, Jacobs B et al (2017) Early predictors of outcome after mild traumatic brain injury (UPFRONT): an observational cohort study. Lancet Neurol 16(7):532\u2013540. https:\/\/doi.org\/10.1016\/S1474-4422(17)30117-5","journal-title":"Lancet Neurol"},{"issue":"11","key":"1499_CR5","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.3390\/jcm8111921","volume":"8","author":"DC Voormolen","year":"2019","unstructured":"Voormolen DC, Haagsma JA, Polinder S, Maas AIR, Steyerberg EW, Vulekovi\u0107 P, Sewalt CA, Gravesteijn BY, Covic A, Andelic N, Plass AM, von Steinbuechel N (2019) Post-Concussion Symptoms in Complicated vs. Uncomplicated Mild Traumatic Brain Injury Patients at Three and Six Months Post-Injury: Results from the CENTER-TBI Study. J Clin Med 8(11):1921. https:\/\/doi.org\/10.3390\/jcm8111921","journal-title":"J Clin Med"},{"issue":"9","key":"1499_CR6","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s004150050254","volume":"245","author":"T Ingebrigtsen","year":"1998","unstructured":"Ingebrigtsen T, Waterloo K, Marup-Jensen S, Attner E, Romner B (1998) Quantification of post-concussion symptoms 3 months after minor head injury in 100 consecutive patients. J Neurol 245(9):609\u2013612. https:\/\/doi.org\/10.1007\/s004150050254","journal-title":"J Neurol"},{"key":"1499_CR7","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.wneu.2015.12.028","volume":"88","author":"H Xu","year":"2016","unstructured":"Xu H, Pi H, Ma L, Su X, Wang J (2016) Incidence of Headache After Traumatic Brain Injury in China: A Large Prospective Study. World Neurosurg 88:289\u2013296. https:\/\/doi.org\/10.1016\/j.wneu.2015.12.028","journal-title":"World Neurosurg"},{"issue":"6","key":"1499_CR8","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1177\/0333102420909865","volume":"40","author":"H Ashina","year":"2020","unstructured":"Ashina H, Iljazi A, Al-Khazali HM, Ashina S, Jensen RH, Amin FM et al (2020) Persistent post-traumatic headache attributed to mild traumatic brain injury: deep phenotyping and treatment patterns. Cephalalgia 40(6):554\u2013564. https:\/\/doi.org\/10.1177\/0333102420909865","journal-title":"Cephalalgia"},{"issue":"10","key":"1499_CR9","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41582-019-0243-8","volume":"15","author":"H Ashina","year":"2019","unstructured":"Ashina H, Porreca F, Anderson T, Amin FM, Ashina M, Schytz HW, Dodick DW (2019) Post-traumatic headache: epidemiology and pathophysiological insights. Nat Rev Neurol 15(10):607\u2013617. https:\/\/doi.org\/10.1038\/s41582-019-0243-8","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"1499_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11910-022-01175-w","volume":"22","author":"H Ashina","year":"2022","unstructured":"Ashina H, Dodick DW (2022) Post-traumatic Headache: Pharmacologic Management and Targeting CGRP Signaling. Curr Neurol Neurosci Rep 22(2):105\u2013111. https:\/\/doi.org\/10.1007\/s11910-022-01175-w","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"6","key":"1499_CR11","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1002\/ana.25915","volume":"88","author":"H Ashina","year":"2020","unstructured":"Ashina H, Iljazi A, Al-Khazali HM, Christensen CE, Amin FM, Ashina M et al (2020) Hypersensitivity to Calcitonin Gene-Related Peptide in Post-Traumatic Headache. Ann Neurol 88(6):1220\u20131228. https:\/\/doi.org\/10.1002\/ana.25915","journal-title":"Ann Neurol"},{"issue":"3","key":"1499_CR12","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/head.14084","volume":"61","author":"H Ashina","year":"2021","unstructured":"Ashina H, Moskowitz MA (2021) Shared biological foundations of post-traumatic headache and migraine. Headache 61(3):558\u2013559. https:\/\/doi.org\/10.1111\/head.14084","journal-title":"Headache"},{"key":"1499_CR13","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2018) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38(1):1\u2013211","DOI":"10.1177\/0333102417738202"},{"issue":"6","key":"1499_CR14","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1177\/0333102420981666","volume":"41","author":"A Iljazi","year":"2021","unstructured":"Iljazi A, Ashina H, Zhuang ZA, Lopez Lopez C, Snellman J, Ashina M, Schytz HW (2021) Hypersensitivity to calcitonin gene-related peptide in chronic migraine. Cephalalgia 41(6):701\u2013710. https:\/\/doi.org\/10.1177\/0333102420981666","journal-title":"Cephalalgia"},{"issue":"14","key":"1499_CR15","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1177\/0333102419882474","volume":"39","author":"S Younis","year":"2019","unstructured":"Younis S, Christensen CE, Toft NM, S\u00f8borg T, Amin FM, Hougaard A, Ashina M (2019) Investigation of distinct molecular pathways in migraine induction using calcitonin gene-related peptide and sildenafil. Cephalalgia 39(14):1776\u20131788. https:\/\/doi.org\/10.1177\/0333102419882474","journal-title":"Cephalalgia"},{"issue":"10","key":"1499_CR16","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1001\/jamaneurol.2018.1675","volume":"75","author":"ALH Vollesen","year":"2018","unstructured":"Vollesen ALH, Snoer A, Beske RP, Guo S, Hoffmann J, Jensen RH, Ashina M (2018) Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks: A Randomized Clinical Trial. JAMA Neurol 75(10):1187\u20131197. https:\/\/doi.org\/10.1001\/jamaneurol.2018.1675","journal-title":"JAMA Neurol"},{"issue":"19","key":"1499_CR17","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1056\/NEJMra1915327","volume":"383","author":"M Ashina","year":"2020","unstructured":"Ashina M (2020) Migraine. N Engl J Med 383(19):1866\u20131876. https:\/\/doi.org\/10.1056\/NEJMra1915327","journal-title":"N Engl J Med"},{"issue":"8","key":"1499_CR18","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(19)30185-1","volume":"18","author":"M Ashina","year":"2019","unstructured":"Ashina M, Hansen JM, Do TP, Melo-Carrillo A, Burstein R, Moskowitz MA (2019) Migraine and the trigeminovascular system-40 years and counting. Lancet Neurol 18(8):795\u2013804. https:\/\/doi.org\/10.1016\/S1474-4422(19)30185-1","journal-title":"Lancet Neurol"},{"issue":"5","key":"1499_CR19","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/head.13529","volume":"59","author":"S Iyengar","year":"2019","unstructured":"Iyengar S, Johnson KW, Ossipov MH, Aurora SK (2019) CGRP and the Trigeminal System in Migraine. Headache 59(5):659\u2013681. https:\/\/doi.org\/10.1111\/head.13529","journal-title":"Headache"},{"issue":"4","key":"1499_CR20","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/j.pain.0000000000000831","volume":"158","author":"S Iyengar","year":"2017","unstructured":"Iyengar S, Ossipov MH, Johnson KW (2017) The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine. Pain 158(4):543\u2013559. https:\/\/doi.org\/10.1097\/j.pain.0000000000000831","journal-title":"Pain"},{"issue":"6","key":"1499_CR21","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1177\/0333102420981688","volume":"41","author":"CM Kopruszinski","year":"2021","unstructured":"Kopruszinski CM, Turnes JM, Swiokla J, Weinstein TJ, Schwedt TJ, Dodick DW, Anderson T, Navratilova E, Porreca F (2021) CGRP monoclonal antibody prevents the loss of diffuse noxious inhibitory controls (DNIC) in a mouse model of post-traumatic headache. Cephalalgia 41(6):749\u2013759. https:\/\/doi.org\/10.1177\/0333102420981688","journal-title":"Cephalalgia"},{"issue":"14","key":"1499_CR22","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1177\/0333102419877662","volume":"39","author":"E Navratilova","year":"2019","unstructured":"Navratilova E, Rau J, Oyarzo J, Tien J, Mackenzie K, Stratton J, Remeniuk B, Schwedt T, Anderson T, Dodick D, Porreca F (2019) CGRP-dependent and independent mechanisms of acute and persistent post-traumatic headache following mild traumatic brain injury in mice. Cephalalgia 39(14):1762\u20131775. https:\/\/doi.org\/10.1177\/0333102419877662","journal-title":"Cephalalgia"},{"issue":"2","key":"1499_CR23","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1177\/0333102416681571","volume":"38","author":"D Bree","year":"2018","unstructured":"Bree D, Levy D (2018) Development of CGRP-dependent pain and headache related behaviours in a rat model of concussion: Implications for mechanisms of post-traumatic headache. Cephalalgia 38(2):246\u2013258. https:\/\/doi.org\/10.1177\/0333102416681571","journal-title":"Cephalalgia"},{"issue":"8","key":"1499_CR24","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1089\/neu.2015.4087","volume":"33","author":"BV Daiutolo","year":"2016","unstructured":"Daiutolo BV, Tyburski A, Clark SW, Elliott MB (2016) Trigeminal Pain Molecules, Allodynia, and Photosensitivity Are Pharmacologically and Genetically Modulated in a Model of Traumatic Brain Injury. J Neurotrauma 33(8):748\u2013760. https:\/\/doi.org\/10.1089\/neu.2015.4087","journal-title":"J Neurotrauma"},{"issue":"10283","key":"1499_CR25","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/S0140-6736(20)32162-0","volume":"397","author":"M Ashina","year":"2021","unstructured":"Ashina M, Terwindt GM, Al-Karagholi MA, de Boer I, Lee MJ, Hay DL, Schulte LH, Hadjikhani N, Sinclair AJ, Ashina H, Schwedt TJ, Goadsby PJ (2021) Migraine: disease characterisation, biomarkers, and precision medicine. Lancet 397(10283):1496\u20131504. https:\/\/doi.org\/10.1016\/S0140-6736(20)32162-0","journal-title":"Lancet"},{"issue":"9","key":"1499_CR26","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1093\/brain\/awz199","volume":"142","author":"MA Al-Karagholi","year":"2019","unstructured":"Al-Karagholi MA, Hansen JM, Guo S, Olesen J, Ashina M (2019) Opening of ATP-sensitive potassium channels causes migraine attacks: a new target for the treatment of migraine. Brain 142(9):2644\u20132654. https:\/\/doi.org\/10.1093\/brain\/awz199","journal-title":"Brain"},{"issue":"10","key":"1499_CR27","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1097\/j.pain.0000000000002238","volume":"162","author":"MA Al-Karagholi","year":"2021","unstructured":"Al-Karagholi MA, Ghanizada H, Waldorff Nielsen CA, Skandarioon C, Snellman J, Lopez-Lopez C, Hansen JM, Ashina M (2021) Opening of BKCa channels causes migraine attacks: a new downstream target for the treatment of migraine. Pain 162(10):2512\u20132520. doi: https:\/\/doi.org\/10.1097\/j.pain.0000000000002238","journal-title":"Pain"},{"issue":"10","key":"1499_CR28","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1177\/0333102410368444","volume":"30","author":"JM Hansen","year":"2010","unstructured":"Hansen JM, Hauge AW, Olesen J, Ashina M (2010) Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura. Cephalalgia 30(10):1179\u20131186. https:\/\/doi.org\/10.1177\/0333102410368444","journal-title":"Cephalalgia"},{"issue":"Pt 1","key":"1499_CR29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/brain\/awn307","volume":"132","author":"HW Schytz","year":"2009","unstructured":"Schytz HW, Birk S, Wienecke T, Kruuse C, Olesen J, Ashina M (2009) PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain 132(Pt 1):16\u201325. https:\/\/doi.org\/10.1093\/brain\/awn307","journal-title":"Brain"},{"issue":"1","key":"1499_CR30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/0333102419864507","volume":"40","author":"H Ghanizada","year":"2020","unstructured":"Ghanizada H, Al-Karagholi MA, Arngrim N, Olesen J, Ashina M (2020) PACAP27 induces migraine-like attacks in migraine patients. Cephalalgia 40(1):57\u201367. https:\/\/doi.org\/10.1177\/0333102419864507","journal-title":"Cephalalgia"},{"issue":"6","key":"1499_CR31","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/ana.26072","volume":"89","author":"H Ghanizada","year":"2021","unstructured":"Ghanizada H, Al-Karagholi MA, Walker CS, Arngrim N, Rees T, Petersen J, Siow A, M\u00f8rch-Rasmussen M, Tan S, O\u2019Carroll SJ, Harris P, Skovgaard LT, J\u00f8rgensen NR, Brimble M, Waite JS, Rea BJ, Sowers LP, Russo AF, Hay DL, Ashina M (2021) Amylin Analog Pramlintide Induces Migraine-like Attacks in Patients. Ann Neurol 89(6):1157\u20131171. https:\/\/doi.org\/10.1002\/ana.26072","journal-title":"Ann Neurol"},{"issue":"20","key":"1499_CR32","doi-asserted-by":"publisher","first-page":"e2488","DOI":"10.1212\/WNL.0000000000011930","volume":"96","author":"H Ghanizada","year":"2021","unstructured":"Ghanizada H, Al-Karagholi MA, Arngrim N, M\u00f8rch-Rasmussen M, Walker CS, Hay DL, Ashina M (2021) Effect of Adrenomedullin on Migraine-Like Attacks in Patients With Migraine: A Randomized Crossover Study. Neurology 96(20):e2488\u2013e2499. https:\/\/doi.org\/10.1212\/WNL.0000000000011930","journal-title":"Neurology"},{"issue":"Pt 11","key":"1499_CR33","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1093\/brain\/awu244","volume":"137","author":"S Guo","year":"2014","unstructured":"Guo S, Olesen J, Ashina M (2014) Phosphodiesterase 3 inhibitor cilostazol induces migraine-like attacks via cyclic AMP increase. Brain 137(Pt 11):2951\u20132959. https:\/\/doi.org\/10.1093\/brain\/awu244","journal-title":"Brain"},{"issue":"1","key":"1499_CR34","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/j.pain.0000000000002008","volume":"162","author":"CE Christensen","year":"2021","unstructured":"Christensen CE, Younis S, Lindberg U, de Koning P, Tolnai D, Paulson OB, Larsson HBW, Amin FM, Ashina M (2021) Intradural artery dilation during experimentally induced migraine attacks. Pain 162(1):176\u2013183. https:\/\/doi.org\/10.1097\/j.pain.0000000000002008","journal-title":"Pain"},{"issue":"1","key":"1499_CR35","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41572-021-00328-4","volume":"8","author":"MD Ferrari","year":"2022","unstructured":"Ferrari MD, Goadsby PJ, Burstein R, Kurth T, Ayata C, Charles A, Ashina M, van den Maagdenberg AMJM, Dodick DW (2022) Migraine. Nat Rev Dis Primers 8(1):2. https:\/\/doi.org\/10.1038\/s41572-021-00328-4","journal-title":"Nat Rev Dis Primers"},{"issue":"44","key":"1499_CR36","doi-asserted-by":"publisher","first-page":"10587","DOI":"10.1523\/JNEUROSCI.2211-17.2017","volume":"37","author":"A Melo-Carrillo","year":"2017","unstructured":"Melo-Carrillo A, Strassman AM, Nir RR, Schain AJ, Noseda R, Stratton J, Burstein R (2017) Fremanezumab-A Humanized Monoclonal Anti-CGRP Antibody-Inhibits Thinly Myelinated (A\u03b4) But Not Unmyelinated (C) Meningeal Nociceptors. J Neurosci 37(44):10587\u201310596. https:\/\/doi.org\/10.1523\/JNEUROSCI.2211-17.2017","journal-title":"J Neurosci"},{"issue":"3","key":"1499_CR37","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/0333102419896760","volume":"40","author":"R Noseda","year":"2020","unstructured":"Noseda R, Schain AJ, Melo-Carrillo A, Tien J, Stratton J, Mai F, Strassman AM, Burstein R (2020) Fluorescently-labeled fremanezumab is distributed to sensory and autonomic ganglia and the dura but not to the brain of rats with uncompromised blood brain barrier. Cephalalgia 40(3):229\u2013240. https:\/\/doi.org\/10.1177\/0333102419896760","journal-title":"Cephalalgia"},{"issue":"1","key":"1499_CR38","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/s41467-022-28204-z","volume":"13","author":"F De Logu","year":"2022","unstructured":"De Logu F, Nassini R, Hegron A, Landini L, Jensen DD, Latorre R, Ding J, Marini M, Souza Monteiro de Araujo D, Ram\u00edrez-Garcia P, Whittaker M, Retamal J, Titiz M, Innocenti A, Davis TP, Veldhuis N, Schmidt BL, Bunnett NW, Geppetti P (2022) Schwann cell endosome CGRP signals elicit periorbital mechanical allodynia in mice. Nat Commun 13(1):646. doi: https:\/\/doi.org\/10.1038\/s41467-022-28204-z","journal-title":"Nat Commun"},{"issue":"1","key":"1499_CR39","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s10194-020-01136-z","volume":"21","author":"H Ashina","year":"2020","unstructured":"Ashina H, Iljazi A, Al-Khazali HM, Eigenbrodt AK, Larsen EL, Andersen AM, Hansen KJ, Br\u00e4uner KB, M\u00f8rch-Jessen T, Chaudhry B, Antic S, Christensen CE, Ashina M, Amin FM, Schytz HW (2020) Efficacy, tolerability, and safety of erenumab for the preventive treatment of persistent post-traumatic headache attributed to mild traumatic brain injury: an open-label study. J Headache Pain 21(1):62. https:\/\/doi.org\/10.1186\/s10194-020-01136-z","journal-title":"J Headache Pain"},{"issue":"Pt 3","key":"1499_CR40","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/brain\/awt369","volume":"137","author":"FM Amin","year":"2014","unstructured":"Amin FM, Hougaard A, Schytz HW, Asghar MS, Lundholm E, Parvaiz AI, de Koning PJ, Andersen MR, Larsson HB, Fahrenkrug J, Olesen J, Ashina M (2014) Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38. Brain 137(Pt 3):779\u2013794. https:\/\/doi.org\/10.1093\/brain\/awt369","journal-title":"Brain"},{"issue":"1","key":"1499_CR41","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s10194-020-01135-0","volume":"14","author":"S Benemei","year":"2020","unstructured":"Benemei S, Labastida-Ram\u00edrez A, Abramova E, Brunelli N, Caronna E, Diana P, Gapeshin R, Hofacker MD, Maestrini I, P\u00edas EM, Mikulenka P, Tikhonova O, Martelletti P, MaassenVanDenBrink A, European Headache Federation School of Advanced Studies (EHF-SAS) (2020) Persistent post-traumatic headache: a migrainous loop or not? The preclinical evidence. J Headache Pain 14(1):90. doi: https:\/\/doi.org\/10.1186\/s10194-020-01135-0","journal-title":"J Headache Pain"},{"key":"1499_CR42","doi-asserted-by":"publisher","unstructured":"Labastida-Ram\u00edrez A, Benemei S, Albanese M, D\u2019Amico A, Grillo G, Grosu O, Ertem DH, Mecklenburg J, Fedorova EP, \u0158ehulka P, di Cola FS, Lopez JT, Vashchenko N, MaassenVanDenBrink A, Martelletti P(2020) ; Persistent post-traumatic headache: a migrainous loop or not? The clinical evidence. J Headache Pain. 2020 May 24;21(1):55. doi: https:\/\/doi.org\/10.1186\/s10194-020-01122-5","DOI":"10.1186\/s10194-020-01122-5"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-022-01499-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-022-01499-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-022-01499-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T12:08:26Z","timestamp":1666008506000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-022-01499-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,17]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1499"],"URL":"https:\/\/doi.org\/10.1186\/s10194-022-01499-5","relation":{},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"value":"1129-2369","type":"print"},{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,17]]},"assertion":[{"value":"27 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed written consent was obtained from each patient before conducting any study-related procedures. The study protocol was approved by the relevant ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared the following potential conflicts of interest with respect to the research, authorship and\/or publication of this article: H.A. reports personal fees from Teva. F.M.A. has been a consultant, speaker, or scientific adviser for Eli Lilly, Lundbeck, Novartis, and Teva, outside of the submitted work. H.W.S. has been a consultant, speaker, or scientific adviser for Novartis, Eli Lilly, Lundbeck, Abbvie, and Teva, outside of the submitted work. All other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"135"}}